Ontology highlight
ABSTRACT: Background
The ACC/AHA cholesterol guidelines recommend patients with peripheral artery disease (PAD) be treated with a moderate to high-intensity statin. The extent to which patients with new or worsening PAD symptoms are offered guideline therapy is unknown.Hypothesis
There is significant variability in rate of guideline-directed statin intensification across clinical practices.Methods
In the PORTRAIT registry, patterns of statin therapy were assessed in 1144 patients at 16 PAD specialty clinics between June 2011 and December 2015 before and after an evaluation for new or worsening claudication symptoms. We documented whether patients were treated with a guideline statin as well as the incidence of statin intensification. Statin intensification was defined as tran
SUBMITTER: Khariton Y
PROVIDER: S-EPMC6489902 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature